Clinical Trial Update: Impact of Chemotherapy Dose Reductions on Survival Outcomes Among Older NSCLC Patients Without Actionable Mutations

View source ↗

Summary

A clinical trial update evaluating whether reducing chemotherapy doses affects survival in older patients with non-small cell lung cancer lacking actionable mut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Malaya | Conditions: Non Small Cell Lung Carcinoma NSCLC | Status: RECRUITING